(Q43039732)

English

Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4.

scientific article published in September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. (English)

1 reference

Europe PubMed Central

12 November 2017

lipopolysaccharide

0 references

toll-like receptor

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

12 November 2017

Keiichi Fujiwara

8

object named as

Keiichi Fujiwara

1 reference

Europe PubMed Central

12 November 2017

author name string

Ryo Tamura

1

1 reference

Europe PubMed Central

12 November 2017

Tatsuo Kanda

2

1 reference

Europe PubMed Central

12 November 2017

Fumio Imazeki

3

1 reference

Europe PubMed Central

12 November 2017

Shuang Wu

4

1 reference

Europe PubMed Central

12 November 2017

Shingo Nakamoto

5

1 reference

Europe PubMed Central

12 November 2017

Takeshi Tanaka

6

1 reference

Europe PubMed Central

12 November 2017

Makoto Arai

7

1 reference

Europe PubMed Central

12 November 2017

Kengo Saito

9

1 reference

Europe PubMed Central

12 November 2017

Takaji Wakita

11

1 reference

Europe PubMed Central

12 November 2017

Hiroshi Shirasawa

12

1 reference

Europe PubMed Central

12 November 2017

Osamu Yokosuka

13

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 September 2011

1 reference

Europe PubMed Central

12 November 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

12 November 2017

204

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

793-801

1 reference

Europe PubMed Central

12 November 2017

Viral hepatocarcinogenesis: from infection to cancer

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Regulation of adaptive immunity by the innate immune system

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Toll-like receptors as targets in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Apoptosis: controlled demolition at the cellular level

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

LPS-induced apoptosis is dependent upon mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Enhanced sensitivity of human hepatoma cells to 5-fluorouracil by small interfering RNA targeting Bcl-2.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Apoptosis in animal models of virus-induced disease

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

TLR3 signaling in a hepatoma cell line is skewed towards apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Alcohol, but not lipopolysaccharide-induced liver apoptosis involves changes in intracellular compartmentalization of apoptotic regulators

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Apoptosome: a platform for the activation of initiator caspases

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Overexpression of granulocyte-macrophage colony-stimulating factor in mouse liver enhances the susceptibility of lipopolysaccharide leading to massive apoptosis of hepatocytes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Deletion of toll-like receptor-4 downregulates protein kinase C-zeta and attenuates liver injury in experimental pancreatitis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Hepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic Cell

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

HIV infection increases HCV-induced hepatocyte apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Targeting Toll-like receptors: emerging therapeutics?

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR381

21 January 2018

Identifiers

10.1093/INFDIS/JIR381

1 reference

Europe PubMed Central

12 November 2017

release_dm6vwkiaunhcvlpyq7zefvvrbm

1 reference

https://api.fatcat.wiki/v0/release/dm6vwkiaunhcvlpyq7zefvvrbm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039732&oldid=1835537772"